Research on Treatment for Angiosarcoma ROCK inhibition There are several treatments available for angiosarcoma, yet the common patient’s five-year survival is still low, approximately, accounting for ...

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/bc3psj/angiosarcoma) has announced the addition of Global Markets Direct's ...

Working in close partnership with patients, scientists at the Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Count Me In have identified new causes of a rare cancer of blood ...

Angiosarcoma is an aggressive malignancy derived from endothelial cells, characterised by its rapid progression, heterogeneity and distinct clinical challenges. As a subset of soft tissue sarcomas, ...

In a new study published in the journal Nature Medicine on February 2020, scientists report some newly discovered reasons for the occurrence of a rare blood vessel wall cancer called angiosarcoma.

The Ken Pribil Jr. Foundation recently made its seventh annual Sarcoma Research Grant, in the amount of $10,000, to support angiosarcoma research being performed by Dr. Cristina Antonescu at Memorial ...

BUFFALO, N.Y., March 08, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for ...

The Ken Pribil Jr. Foundation recently made its eighth annual Sarcoma Research Grant to support angiosarcoma research being performed at Memorial Sloan Kettering Cancer Center (MSK) in New York, New ...

ROCKVILLE CENTRE, N.Y., Jan. 9, 2019 /PRNewswire-PRWeb/ -- The Ken Pribil Jr. Foundation recently made its fifth annual Sarcoma Research Grant in the amount of $15,000 to support targeted angiosarcoma ...